Table of Contents

2018-2023 Global Oncology Ablation Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Oncology Ablation Consumption 2013-2023
  • 2.1.2 Oncology Ablation Consumption CAGR by Region
• 2.2 Oncology Ablation Segment by Type
  • 2.2.1 Radiofrequency Ablation (RFA)
  • 2.2.2 Microwave Ablation (MWA)
• 2.3 Oncology Ablation Consumption by Type
  • 2.3.1 Global Oncology Ablation Consumption Market Share by Type (2013-2018)
  • 2.3.2 Global Oncology Ablation Revenue and Market Share by Type (2013-2018)
  • 2.3.3 Global Oncology Ablation Sale Price by Type (2013-2018)
• 2.4 Oncology Ablation Segment by Application
  • 2.4.1 Liver
  • 2.4.2 Prostate
  • 2.4.3 Other
• 2.5 Oncology Ablation Consumption by Application
  • 2.5.1 Global Oncology Ablation Consumption Market Share by Application (2013-2018)
  • 2.5.2 Global Oncology Ablation Value and Market Share by Application (2013-2018)
  • 2.5.3 Global Oncology Ablation Sale Price by Application (2013-2018)

3 Global Oncology Ablation by Players

• 3.1 Global Oncology Ablation Sales Market Share by Players
  • 3.1.1 Global Oncology Ablation Sales by Players (2016-2018)
  • 3.1.2 Global Oncology Ablation Sales Market Share by Players (2016-2018)
• 3.2 Global Oncology Ablation Revenue Market Share by Players
  • 3.2.1 Global Oncology Ablation Revenue by Players (2016-2018)
  • 3.2.2 Global Oncology Ablation Revenue Market Share by Players (2016-2018)
• 3.3 Global Oncology Ablation Sale Price by Players
• 3.4 Global Oncology Ablation Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Oncology Ablation Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Oncology Ablation Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Oncology Ablation by Regions

• 4.1 Oncology Ablation by Regions
  • 4.1.1 Global Oncology Ablation Consumption by Regions
  • 4.1.2 Global Oncology Ablation Value by Regions
• 4.2 Americas Oncology Ablation Consumption Growth
• 4.3 APAC Oncology Ablation Consumption Growth
• 4.4 Europe Oncology Ablation Consumption Growth
• 4.5 Middle East & Africa Oncology Ablation Consumption Growth

5 Americas

• 5.1 Americas Oncology Ablation Consumption by Countries
  • 5.1.1 Americas Oncology Ablation Consumption by Countries (2013-2018)
  • 5.1.2 Americas Oncology Ablation Value by Countries (2013-2018)
• 5.2 Americas Oncology Ablation Consumption by Type
• 5.3 Americas Oncology Ablation Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Oncology Ablation Consumption by Countries
  • 6.1.1 APAC Oncology Ablation Consumption by Countries (2013-2018)
  • 6.1.2 APAC Oncology Ablation Value by Countries (2013-2018)
• 6.2 APAC Oncology Ablation Consumption by Type
• 6.3 APAC Oncology Ablation Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Oncology Ablation by Countries
  • 7.1.1 Europe Oncology Ablation Consumption by Countries (2013-2018)
  • 7.1.2 Europe Oncology Ablation Value by Countries (2013-2018)
• 7.2 Europe Oncology Ablation Consumption by Type
• 7.3 Europe Oncology Ablation Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Oncology Ablation by Countries
  • 8.1.1 Middle East & Africa Oncology Ablation Consumption by Countries (2013-2018)
  • 8.1.2 Middle East & Africa Oncology Ablation Value by Countries (2013-2018)
• 8.2 Middle East & Africa Oncology Ablation Consumption by Type
• 8.3 Middle East & Africa Oncology Ablation Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Oncology Ablation Distributors
• 10.3 Oncology Ablation Customer

11 Global Oncology Ablation Market Forecast

• 11.1 Global Oncology Ablation Consumption Forecast (2018-2023)
• 11.2 Global Oncology Ablation Forecast by Regions
  • 11.2.1 Global Oncology Ablation Forecast by Regions (2018-2023)
  • 11.2.2 Global Oncology Ablation Value Forecast by Regions (2018-2023)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Oncology Ablation Forecast by Type
• 11.8 Global Oncology Ablation Forecast by Application

12 Key Players Analysis

• 12.1 Philips
  • 12.1.1 Company Details
  • 12.1.2 Oncology Ablation Product Offered
  • 12.1.3 Philips Oncology Ablation Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.1.4 Main Business Overview
  • 12.1.5 Philips News
• 12.2 Biomedical
  • 12.2.1 Company Details
  • 12.2.2 Oncology Ablation Product Offered
  • 12.2.3 Biomedical Oncology Ablation Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.2.4 Main Business Overview
  • 12.2.5 Biomedical News
• 12.3 Medtronic
  • 12.3.1 Company Details
  • 12.3.2 Oncology Ablation Product Offered
  • 12.3.3 Medtronic Oncology Ablation Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.3.4 Main Business Overview
  • 12.3.5 Medtronic News
• 12.4 AngioDynamics
  • 12.4.1 Company Details
  • 12.4.2 Oncology Ablation Product Offered
  • 12.4.3 AngioDynamics Oncology Ablation Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.4.4 Main Business Overview
  • 12.4.5 AngioDynamics News
• 12.5 Covidien
  • 12.5.1 Company Details
  • 12.5.2 Oncology Ablation Product Offered
  • 12.5.3 Covidien Oncology Ablation Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.5.4 Main Business Overview
  • 12.5.5 Covidien News
• 12.6 Ethicon
  • 12.6.1 Company Details
  • 12.6.2 Oncology Ablation Product Offered
  • 12.6.3 Ethicon Oncology Ablation Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.6.4 Main Business Overview
  • 12.6.5 Ethicon News
• 12.7 ZenoMed
  • 12.7.1 Company Details
  • 12.7.2 Oncology Ablation Product Offered
  • 12.7.3 ZenoMed Oncology Ablation Sales, Revenue, Price and Gross Margin (2016-2018)
  • 12.7.4 Main Business Overview
  • 12.7.5 ZenoMed News

...

13 Research Findings and Conclusion

Oncology ablation for cancer is a minimally invasive procedure that uses electrical energy and heat to destroy cancer cells.

According to this study, over the next five years the Oncology Ablation market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Oncology Ablation business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Ablation market by product type, application, key manufacturers and key regions and countries.

This study considers the Oncology Ablation value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Radiofrequency Ablation (RFA)
Microwave Ablation (MWA)
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Liver
Prostate
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Philips
Biomedical
Medtronic
AngioDynamics
Covidien
Ethicon
ZenoMed
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Oncology Ablation consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Oncology Ablation market by identifying its various subsegments.
Focuses on the key global Oncology Ablation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oncology Ablation with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Oncology Ablation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.